Baker Tilly Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$537K Sell
1,484
-2
-0.1% -$685 0.11% 158
2026
Q1
$523K Buy
1,486
+14
+1% +$4.99K 0.13% 151
2025
Q4
$482K Buy
1,472
+25
+2% +$7.93K 0.12% 163
2025
Q3
$408K Buy
1,447
+538
+59% +$156K 0.09% 175
2025
Q2
$254K Buy
909
+47
+5% +$13.3K 0.09% 206
2025
Q1
$269K Buy
862
+21
+2% +$6.2K 0.11% 195
2024
Q4
$219K Buy
841
+4
+0.5% +$1.19K 0.09% 220
2024
Q3
$270K Sell
837
-667
-44% -$218K 0.12% 195
2024
Q2
$470K Sell
1,504
-1,442
-49% -$424K 0.19% 129
2024
Q1
$838K Buy
2,946
+44
+2% +$12.9K 0.15% 148
2023
Q4
$836K Sell
2,902
-107
-4% -$29.2K 0.14% 163
2023
Q3
$809K Sell
3,009
-1,482
-33% -$370K 0.13% 156
2023
Q2
$997K Sell
4,491
-230
-5% -$53.4K 0.1% 198
2023
Q1
$1.14M Sell
4,721
-1,381
-23% -$339K 0.13% 177
2022
Q4
$1.6M Buy
6,102
+22
+0.4% +$5.9K 0.2% 120
2022
Q3
$1.37M Sell
6,080
-31
-0.5% -$7.51K 0.19% 117
2022
Q2
$1.49M Sell
6,111
-151
-2% -$37K 0.2% 111
2022
Q1
$1.51M Buy
6,262
+346
+6% +$79.5K 0.17% 124
2021
Q4
$1.33M Sell
5,916
-430
-7% -$90.8K 0.14% 152
2021
Q3
$1.35M Buy
6,346
+335
+6% +$77.1K 0.18% 113
2021
Q2
$1.47M Buy
6,011
+33
+0.6% +$8.12K 0.24% 91
2021
Q1
$1.49M Buy
5,978
+1,983
+50% +$473K 0.3% 81
2020
Q4
$919K Buy
+3,995
New +$921K 0.28% 87

Other funds holding AMGN

Baker Tilly Wealth Management's AMGN Position: Q2 2026 in Review

Baker Tilly Wealth Management reduced its Amgen (AMGN) stake by 0.13% in Q2 2026, selling an estimated $685 and leaving 1,484 shares worth $537K. The position accounts for 0.11% of the portfolio, ranked #158.

Baker Tilly Wealth Management first reported a position in AMGN in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.6M in Q4 2022. 1,338 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Baker Tilly Wealth Management held 1,484 shares of Amgen worth $537K as of Q2 2026.
  • Baker Tilly Wealth Management sold 2 Amgen shares in Q2 2026, an estimated $685.
  • Amgen made up 0.11% of Baker Tilly Wealth Management's portfolio in Q2 2026, its #158 holding.
  • Baker Tilly Wealth Management first reported a position in Amgen in Q4 2020 and has held it in 23 quarters since.
  • Baker Tilly Wealth Management's Amgen position peaked at $1.6M in Q4 2022.
  • 1,338 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Baker Tilly Wealth Management's 13F filing for Q2 2026, filed 17 Jul 2026.